All investigators in the field of clinical pharmacy and clinical pharmacology, ACCP members and nonmembers alike, are invited to submit abstracts to be considered for presentation at the ACCP Updates in Therapeutics® 2019. ACCP’s April meeting delivers specialty certification preparatory review and recertification courses, ACCP Academy programming, the Patient-Centered Team-Based Care Forum, and scientific poster presentations. Submit an abstract and plan to join us April 26–28, 2019, in St. Louis, Missouri. All poster presenters must be registered for one of the meeting's programs (i.e., Updates in Therapeutics, ACCP Academy, Patient-Centered Team-Based Practice Forum, or Emerge from the Crowd [students only]).

All abstracts accepted and presented by the designated presenting author, except for “Encore” and “Research-in-Progress” presentations, will have full-text abstracts published online in JACCP, an official journal of the ACCP. Only the abstract title, authors, and original citation will be published for “Encore” presentations. All accepted abstracts will be published full-text in the ACCP Meeting app.

To review the complete submission instructions, guidelines, and review criteria, and to submit an abstract visit the ACCP website.

Updates in Therapeutics® 2019
April 27-28, 2019

The poster presentation session (Saturday, April 27th from 5:30 to 7:00 p.m.) is scheduled to maximize attendance of registrants from Updates in Therapeutics®, the Academy, the Patient-Centered Team-Based Practice Forum, and Emerge from the Crowd (students only).

Learn More

The poster session is are open (free) to all attendees registered for Updates in Therapeutics®, the Academy, the Patient-Centered Team-Based Practice Forum or Emerge from the Crowd.

Travel information for the ACCP Updates in Therapeutics® meeting includes information about the headquarters hotel and online hotel reservations, details on getting to St. Louis, and information on how to request a letter of invitation to ACCP Updates in Therapeutics®.

Learn More